Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eleven Biotherapeutics Inc (NASDAQ:EBIO)

3.41
Delayed Data
As of 3:59pm ET
 -0.12 / -3.40%
Today’s Change
2.25
Today|||52-Week Range
13.78
-71.30%
Year-to-Date

Today’s Trading

Previous close3.53
Today’s open3.40
Day’s range3.34 - 3.75
Volume361,972
Average volume (3 months)780,579
Market cap$68.4M
Dividend yield--
Data as of 3:59pm ET, 09/01/2015

Growth & Valuation

Earnings growth (last year)-66.90%
Earnings growth (this year)+22.78%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+68.14%
P/E ratioNM
Price/Sales77.56
Price/Book1.72

Competitors

 Today’s
change
Today’s
% change
NNVCNanoViricides Inc-0.08-6.72%
EVARLombard Medical Inc-0.06-1.60%
BLPHBellerophon Therapeu...-0.54-10.63%
ORMPOramed Pharmaceutica...-0.07-1.25%
Data as of 4:01pm ET, 09/01/2015

Financials

Next reporting dateNovember 12, 2015
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$2.2M
Annual profit (last year)-$34.2M
Net profit margin-1,522.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Abbie C. Celniker
Chief Financial &
Accounting Officer
John J. McCabe
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers